Ascend Wellness Holdings, Inc.
AAWHOTCHealthcare● Active
$0.56
+$0.00(+0.00%)
Market Cap$114273799
P/E Ratio—
52W High$1.2
52W Low$0.26
Ascend Wellness Holdings, Inc. (AAWH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AAWH · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.15
Est. -$0.13 · -15.4%
Revenue
$0.12B
Est. $0.12B · +1.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
AAWH reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.06 | — | — | — | $0.12B | — |
| ▼ Q2 FY2026 | May 13, 2026 | -$0.13 | -$0.15 | -15.4% | $0.12B | $0.12B | +1.2% |
| ▼ Q1 FY2026 | Mar 12, 2026 | -$0.12 | -$0.24 | -100.0% | $0.12B | $0.12B | -1.3% |
| ▼ Q4 FY2025 | Nov 10, 2025 | -$0.10 | -$0.13 | -30.0% | $0.12B | $0.12B | +2.0% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -$0.07 | -$0.12 | -71.4% | $0.13B | $0.13B | -1.1% |
| ▼ Q2 FY2025 | May 12, 2025 | -$0.08 | -$0.09 | -12.5% | $0.13B | $0.13B | -1.5% |
| ▲ Q1 FY2025 | Mar 12, 2025 | -$0.10 | -$0.08 | +20.0% | $0.14B | $0.14B | -2.5% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$0.10 | -$0.13 | -30.0% | $0.14B | $0.14B | +1.1% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.06
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Miss
EPS Actual
-$0.15
EPS Est.
-$0.13
EPS Surpr.
-15.4%
Revenue
$0.12B
Q1 FY2026
Mar 12, 2026Miss
EPS Actual
-$0.24
EPS Est.
-$0.12
EPS Surpr.
-100.0%
Revenue
$0.12B
Q4 FY2025
Nov 10, 2025Miss
EPS Actual
-$0.13
EPS Est.
-$0.10
EPS Surpr.
-30.0%
Revenue
$0.12B
Q3 FY2025
Aug 7, 2025Miss
EPS Actual
-$0.12
EPS Est.
-$0.07
EPS Surpr.
-71.4%
Revenue
$0.13B
Q2 FY2025
May 12, 2025Miss
EPS Actual
-$0.09
EPS Est.
-$0.08
EPS Surpr.
-12.5%
Revenue
$0.13B
Q1 FY2025
Mar 12, 2025Beat
EPS Actual
-$0.08
EPS Est.
-$0.10
EPS Surpr.
+20.0%
Revenue
$0.14B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$0.13
EPS Est.
-$0.10
EPS Surpr.
-30.0%
Revenue
$0.14B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Q3 FY2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q2 FY2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q1 FY2027 | $-0.08 | $-0.07 | $-0.07 | 1 |
| Q4 FY2026 | $-0.05 | $-0.05 | $-0.05 | 1 |
| Q3 FY2026 | $-0.06 | $-0.05 | $-0.04 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 13, 2026 | -15.4% | $0.55 | $0.57 | +3.64% |
| ▼ Q1 FY2026 | Mar 12, 2026 | -100.0% | $0.50 | $0.50 | -0.93% |
| ▼ Q4 FY2025 | Nov 10, 2025 | -30.0% | $0.61 | $0.64 | +4.96% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -71.4% | $0.47 | $0.47 | -0.84% |
| ▼ Q2 FY2025 | May 12, 2025 | -12.5% | $0.37 | $0.37 | +0.00% |
| ▲ Q1 FY2025 | Mar 12, 2025 | +20.0% | $0.30 | $0.31 | +3.33% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -30.0% | $0.50 | $0.56 | +12.00% |
| ▼ Q3 FY2024 | Aug 5, 2024 | -25.0% | $1.07 | $0.84 | -21.50% |
Q2 FY2026+3.64%
Report Date
May 13, 2026
EPS Beat/Miss
-15.4%
Price Before
$0.55
Price After
$0.57
Q1 FY2026-0.93%
Report Date
Mar 12, 2026
EPS Beat/Miss
-100.0%
Price Before
$0.50
Price After
$0.50
Q4 FY2025+4.96%
Report Date
Nov 10, 2025
EPS Beat/Miss
-30.0%
Price Before
$0.61
Price After
$0.64
Q3 FY2025-0.84%
Report Date
Aug 7, 2025
EPS Beat/Miss
-71.4%
Price Before
$0.47
Price After
$0.47
Q2 FY2025+0.00%
Report Date
May 12, 2025
EPS Beat/Miss
-12.5%
Price Before
$0.37
Price After
$0.37
Q1 FY2025+3.33%
Report Date
Mar 12, 2025
EPS Beat/Miss
+20.0%
Price Before
$0.30
Price After
$0.31
Q4 FY2024+12.00%
Report Date
Nov 12, 2024
EPS Beat/Miss
-30.0%
Price Before
$0.50
Price After
$0.56
Q3 FY2024-21.50%
Report Date
Aug 5, 2024
EPS Beat/Miss
-25.0%
Price Before
$1.07
Price After
$0.84
Avg Beat Reaction+3.33%
Avg Miss Reaction-0.38%
Beat Rate1 / 8 quarters
Largest Move-21.50% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AAWH ends December
Ascend Wellness Holdings, Inc. (AAWH) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.15 — missing the analyst consensus of $-0.13 by -15.4%. The next AAWH earnings date is expected around September 1, 2026.
Each quarter, investors track AAWH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AAWH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AAWH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AAWH earnings · 5 questionsAscend Wellness Holdings, Inc.'s next earnings report is expected around September 1, 2026. AAWH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AAWH historically reports after market close (AMC).
AAWH earnings datewhen is AAWH earningsAAWH next earnings datewhen does AAWH report earningsAAWH earnings calendar
▸ Source: FMP · Ascend Wellness Holdings, Inc. SEC filings · US GAAP · Ascend Wellness Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026